Impact of invasive bladder cancer and orthotopic urinary diversion on general health-related quality of life: An SF-36 survey

Hautmann RE, de Petriconi RC, Pfeiffer C and Volkmer BG: Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients. Eur Urol. 61:1039–1047. 2012. View Article : Google Scholar : PubMed/NCBI

Kübler H and Gschwend JE: Ileal neobladder in women with bladder cancer: cancer control and functional aspects. Curr Opin Urol. 21:478–482. 2011.PubMed/NCBI

Erber B, Schrader M, Miller K, et al: Morbidity and quality of life in bladder cancer patients following cystectomy and urinary diversion: a single-institution comparison of ileal conduit versus orthotopic neobladder. ISRN Urol. 2012. View Article : Google Scholar

Hashine K, Miura N, Numata K, Shirato A, Sumiyoshi Y and Kataoka M: Health-related quality of life after bladder preservation therapy for muscle invasive bladder cancer. Int J Urol. 15:403–406. 2008. View Article : Google Scholar : PubMed/NCBI

Jeong IG, You D, Kim J, et al: Factors associated with nonorthotopic urinary diversion after radical cystectomy. World J Urol. 30:815–820. 2012. View Article : Google Scholar : PubMed/NCBI

Philip J, Manikandan R, Venugopal S, Desouza J and Javle PM: Orthotopic neobladder versus ileal conduit urinary diversion after cystectomy - a quality-of-life based comparison. Ann R Coll Surg Engl. 91:565–569. 2009. View Article : Google Scholar : PubMed/NCBI

Takenaka A, Hara I, Soga H, et al: Assessment of long-term quality of life in patients with orthotopic neobladder followed for more than 5 years. Int Urol Nephrol. 43:749–754. 2011.PubMed/NCBI

Cesarino CB, Beccaria LM, Aroni MM, Rodrigues LC and Pacheco Sda S: Quality of life of patients with implantable cardioverser-defibrillator: the usage of SF-36 questionnaire. Rev Bras Cir Cardiovasc. 26:238–243. 2011.PubMed/NCBI

Maurino J, Cordero L and Ballesteros J: The subjective well-being under neuroleptic scale - short version (SWN-K) and the SF-36 health survey as quality of life measures in patients with schizophrenia. Patient Prefer Adherence. 6:83–85. 2012. View Article : Google Scholar : PubMed/NCBI

McPherson A and Martin CR: A review of the measurement properties of the 36-item short-form health survey (SF-36) to determine its suitability for use in an alcohol-dependent population. J Psychiatr Ment Health Nurs. Mar 27–2012.(Epub ahead of print).

Wan C, Tu X, Messing S, et al: Development and validation of the general module of the system of quality of life instruments for chronic diseases and its comparison with SF-36. J Pain Symptom Manage. 42:93–104. 2011. View Article : Google Scholar : PubMed/NCBI

Kang SG, Ko YH, Jang HA, et al: Initial experience of robot-assisted radical cystectomy with total intracorporeal-urinary diversion: comparison with extracorporeal method. J Laparoendosc Adv Surg Tech A. 22:456–462. 2012. View Article : Google Scholar

Goossens-Laan CA, Kil PJ, Ruud Bosch JL and De Vries J: Pre-diagnosis quality of life (QoL) in patients with hematuria: comparison of bladder cancer with other causes. Qual Life Res. Mar 30–2012.(Epub ahead of print).

Miyanaga N, Akaza H, Shinohara N, et al: Assessment of QOL and survival for patients undergoing radical cystectomy or bladder preservation for invasive bladder cancer. Nihon Hinyokika Gakkai Zasshi. 90:445–453. 1999.(In Japanese).

Ridolo E, Baiardini I, Meschi T, et al: Erratum to: HRQoL questionnaire evaluation in lactose intolerant patients with adverse reactions to foods. Intern Emerg Med. Feb 24–2012.(Epub ahead of print).

Velanovich V, Younga J, Bhandarkar V, et al: A single, global patient-centered measure from the SF-36 instrument to assess surgical outcomes and quality of life: a pilot study. World J Surg. 36:2045–2050. 2012. View Article : Google Scholar : PubMed/NCBI